Bicara Therapeutics BCAX Q1 2026 Earnings EPS Miss Overshadowed by Pipeline Progress as Stock Rises 4 TERN Q4 2025 Earnings Narrower Than Expected Loss as Pipeline Progress Continues TREX Q1 2026 Earnings Strong EPS Beat Signals Robust Demand for Composite Decking BNAI Q3 2025 Earnings NarrowerThanExpected Loss Drives Positive Surprise Despite Revenue Absence IPW Q3 2025 Earnings Narrow Loss Misses Estimates Stock Rises on Resilience ABBV Q1 2026 Earnings EPS Edges Past Estimates as Stock Slips PostRelease Cartesian Therapeutics RNAC Q1 2026 Earnings WiderThanAnticipated Loss Masks Progress in CART Pipeline HYPR Q1 2026 Earnings EPS Beat Highlights Cost Discipline Amid Disclosed Revenue Gap ALOY Q1 2024 Earnings EPS Misses Estimates Significantly Stock Rises Unexpectedly CANF Q4 2023 Earnings EPS Surges Past Estimates as Clinical Progress Continues ASIX Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions TBCH Q1 2026 Earnings EPS Misses Estimates Sharply Yet Stock Surges Over 11